- Home
- TWST
as of 12-02-2025 3:44pm EST
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.
| Founded: | 2013 | Country: | United States |
| Employees: | N/A | City: | SOUTH SAN FRANCISCO |
| Market Cap: | 1.6B | IPO Year: | 2018 |
| Target Price: | $46.33 | AVG Volume (30 days): | 1.9M |
| Analyst Decision: | Buy | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.30 | EPS Growth: | N/A |
| 52 Week Low/High: | $23.30 - $55.33 | Next Earning Date: | 11-14-2025 |
| Revenue: | $376,572,000 | Revenue Growth: | 20.32% |
| Revenue Growth (this year): | 17.89% | Revenue Growth (next year): | 16.81% |
AI-Powered TWST Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Twist Bioscience Corporation (TWST)
Chief Accounting Officer
Avg Cost/Share
$28.71
Shares
822
Total Value
$23,599.21
Owned After
66,143
SEC Form 4
Chief Executive Officer
Avg Cost/Share
$26.50
Shares
2,663
Total Value
$70,578.82
Owned After
878,173
SEC Form 4
SVP of Human Resources
Avg Cost/Share
$26.50
Shares
598
Total Value
$15,849.09
Owned After
167,789
SEC Form 4
See Remarks
Avg Cost/Share
$26.50
Shares
757
Total Value
$20,063.15
Owned After
145,402
SEC Form 4
Chief Accounting Officer
Avg Cost/Share
$26.50
Shares
229
Total Value
$6,069.30
Owned After
66,143
SEC Form 4
President and COO
Avg Cost/Share
$26.50
Shares
1,776
Total Value
$47,070.22
Owned After
332,883
SEC Form 4
Chief Financial Officer
Avg Cost/Share
$26.50
Shares
887
Total Value
$23,508.60
Owned After
142,769
SEC Form 4
Director
Avg Cost/Share
$24.77
Shares
7,044
Total Value
$174,479.88
Owned After
14,859
SEC Form 4
Chief Executive Officer
Avg Cost/Share
$32.08
Shares
9,774
Total Value
$313,544.06
Owned After
878,173
SVP of Human Resources
Avg Cost/Share
$32.08
Shares
2,168
Total Value
$69,548.14
Owned After
167,789
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| WERNER ROBERT F. | TWST | Chief Accounting Officer | Nov 24, 2025 | Sell | $28.71 | 822 | $23,599.21 | 66,143 | |
| Leproust Emily M. | TWST | Chief Executive Officer | Nov 21, 2025 | Sell | $26.50 | 2,663 | $70,578.82 | 878,173 | |
| Green Paula | TWST | SVP of Human Resources | Nov 21, 2025 | Sell | $26.50 | 598 | $15,849.09 | 167,789 | |
| Cho Dennis | TWST | See Remarks | Nov 21, 2025 | Sell | $26.50 | 757 | $20,063.15 | 145,402 | |
| WERNER ROBERT F. | TWST | Chief Accounting Officer | Nov 21, 2025 | Sell | $26.50 | 229 | $6,069.30 | 66,143 | |
| Finn Patrick John | TWST | President and COO | Nov 21, 2025 | Sell | $26.50 | 1,776 | $47,070.22 | 332,883 | |
| Laponis Adam | TWST | Chief Financial Officer | Nov 21, 2025 | Sell | $26.50 | 887 | $23,508.60 | 142,769 | |
| JOHANNESSEN JAN | TWST | Director | Nov 18, 2025 | Sell | $24.77 | 7,044 | $174,479.88 | 14,859 | |
| Leproust Emily M. | TWST | Chief Executive Officer | Nov 3, 2025 | Sell | $32.08 | 9,774 | $313,544.06 | 878,173 | |
| Green Paula | TWST | SVP of Human Resources | Nov 3, 2025 | Sell | $32.08 | 2,168 | $69,548.14 | 167,789 |
Compare TWST vs Leading Stocks
See how TWST stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "TWST Twist Bioscience Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.